Filing Details
- Accession Number:
- 0001127602-10-002098
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-01-25 12:00:00
- Reporting Period:
- 2010-01-22
- Filing Date:
- 2010-01-25
- Accepted Time:
- 2010-01-25 14:12:50
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 882796 | Biocryst Pharmaceuticals Inc | BCRX | Biological Products, (No Disgnostic Substances) (2836) | 621413174 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1395238 | David Mccullough | 2190 Parkway Lake Dr Birmingham AL 35244 | Vp | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2010-01-22 | 14,271 | $7.02 | 5,626 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Transacted under a 10b5-1 plan that was adopted on 12/14/09.
Billionaire Hedge Funds
